Study
Insulin Glargine and Lantus(R) Trial 1 - Daytona Beach, Florida - #CCRI SD-01
Summary
To compare the effectiveness, safety and tolerability of a newly developed formulation of Insulin Glargine with Lantus(R)
Qualifications - Inclusions & Exclusions
Inclusion:
Patients with Type 2 Diabetes
Age 18 or greater
Have been taking Insulin Glargine greater than 42 units

Exclusion:
Hemoglobin A1c is between 7 and 10,
Diabetes type other than Type 2
Use of an insuline pump in the last 6 months before screening visit
Any contraindication to use of insuline glargine
Diabetic Retinopathywith laser or surgical treatment in the 3 months before screening
Congestive Heart Failure
History of drug or alcohol abuse within the last 3 months prior to screening
Compensation for Time and Travel
Participants who qualify will receive reimbursement for their time and participation for an amount up to $640
Location
Daytona Beach, Volusia County
Daytona Beach, Florida 32117
In/Outpatient
Outpatient
Learn More
* Required Fields
Email:
*
First Name: *
Last Name: *
Daytime Phone:
Evening Phone:
Source:
If Other:
Comments: